Yahoo Search Busca da Web

Resultado da Busca

  1. 21 de fev. de 2021 · Brain metastases (BM) from colorectal cancer (CRC) are rare. There is little available information regarding incidence, risk factors, prognostic factors, treatment, and overall survival (OS). In this systematic review we performed a research of the current literature and exposed an average incidence of 2.10%.

  2. 22 de jan. de 2021 · In this study, we investigated the impact of different treatments for colorectal cancer patients with brain metastases. Methods: We identified stage 4 colorectal adenocarcinoma patients with brain metastasis using the National Cancer Database diagnosed between 2010 and 2015.

  3. 10 de out. de 2022 · To investigate the clinical characteristics, survival, prognostic factors, and treatment of brain metastasis (BM) from colorectal cancer (CRC). Twenty-one patients with BM from CRC were retrospectively reviewed.

  4. Brain metastases (BM) from colorectal cancer (CRC) are a rare event. However, the implications for affected patients are severe, and the incidence has been reported to be increasing. For clinicians, knowledge about the characteristics associated with BM is important and could lead to earlier diagnosis and improved survival. Method:

  5. 4 de fev. de 2020 · Background: More than 50% of colorectal cancer (CRC) patients will develop metastatic disease. Brain metastasis (BM) from colorectal cancer is uncommon (0.6-1.36%). This study aims to investigate the patient characteristics, treatment modalities and prognostic factors in this rare population.

  6. Brain metastasis (BM) in colorectal cancer patients is rare and is associated with dismal outcomes. Our study aims to evaluate the incidence and predictors of BM in patients with colorectal cancer. Methods. We performed a retrospective analysis (2010–2017) of patients with a primary diagnosis of colorectal cancer (CRC).

  7. 21 de fev. de 2021 · Brain Metastases from Colorectal Cancer: A Systematic Review of the Literature and Meta-Analysis to Establish a Guideline for Daily Treatment. by. Sophie Müller. 1, Franziska Köhler. 1, Anne Hendricks. 1, Carolin Kastner. 1, Kevin Börner. 1, Johannes Diers. 1, Johan F. Lock. 1, Bernhard Petritsch. 2, Christoph-Thomas Germer. 1,3 and.